Endo Reaches $10M Deal With SF Ahead Of Opioid Trial
By Hailey Konnath · April 20, 2022, 11:01 PM EDT
Endo Pharmaceuticals has agreed to pay $10 million over the course of 10 years to resolve the city of San Francisco's claims stemming from the drugmaker's role in the opioid crisis,...
To view the full article, register now.